List of Contributors
Preface
Chapter 1 Herpes: History and Classification
I. Introduction
II. Development of the Concept of the Herpes Group of Viruses, 500 B.C. to 1972 A.D.
III. Subclassification of the Herpesviruses
IV. Summary and Conclusions
References
Chapter 2 Morphology
I. Introduction
II. Morphology of Particles of Herpes Simplex Virus
III. Other Herpesviruses
IV. Morphology and Clinical Diagnosis
V. Morphology and Classification of Herpesviruses
References
Chapter 3 The Physical and Chemical Properties of the Herpesviruses
1. Introduction
II. The Herpes Virion—Physical Properties
III. The Herpes Virion—Chemical Properties
IV. Resistance of the Herpesviruses to Inactivation
V. Conclusion
References
Chapter 4 Replication—Biological Aspects
I. Introduction
II. Host Range
III. Environmental Factors Affecting Virus Growth
IV. Virus Growth Cycle
V. Cytopathogenic Effect and Quantitation of Virus Growth
VI. Variation and Genetics
References
Chapter 5 Replication of the Viruses—Morphological Aspects
I. Introduction
II. Attachment and Penetration
III. Growth of the Virus
IV. Conclusion
References
Chapter 6 Replication—Biochemical Aspects
I. Introduction
II. Effect of Infection on Macromolecular Synthesis
III. RNA Synthesis
IV. DNA Synthesis
V. Protein Synthesis
VI. Membrane Alterations
VII. Virion Assembly
VIII. Abortive Infection
IX. Enzymology of the Infected Cells
X. Control of the Infective Process
References
Chapter 7 Immunological Relationships
I. Serological Tests
II. Immunology of Herpesviruses
References
Chapter 8 Interference and Interferon with Respect to Herpesviruses
I. Introduction
II. Interference—Possibly Mediated by Interferon
III. Interference Not Mediated by Interferon
IV. Relative Resistance of Herpesviruses to Interferon and Poly rI:Poly rC
V. Induction of Interferon
VI. Dual Infections
VII. Conclusion
References
Chapter 9 Persistent and Latent Infections
I. Introduction and Definition of Terms
II. In Vivo Studies
III. Latency In Vitro
IV. Transformation of Cells In Vitro
V. Recapitulation
References
Chapter 10 Herpes Simplex Virus
I. Introduction
II. Pathology and Pathogenesis
III. Epidemiology
IV. Immunity to Herpesvirus
V. Clinical Manifestations of Herpesvirus Type 1
VI. Clinical Manifestations of Herpesvirus Type 2
VII. Herpesvirus Type 2 and Cervical Cancer
VIII. Laboratory Diagnosis
IX. Conclusion
References
Chapter 11 Varicella—Zoster Viruses
I. Introduction
II. Clinical Features and Diagnosis
III. Pathology and Pathogenesis
IV. Immunity
V. Epidemiology
References
Chapter 12 Cytomegaloviruses
I. Introduction
II. Disease States Associated with CMV (Essential Clinical Features)
III. CMV in Animals
IV. Pathogenesis and Pathology
V. Immunity
VI. Epidemiology
VII. Treatment, Prevention, and Control
VIII. Summary
References
Chapter 13 The Simian Herpesviruses
I. Introduction
II. Introduction to and Origin of the Simian Herpesviruses
III. Nature of Infections Produced
IV. Distribution and Prevalence
V. Epidemiological Features
VI. Diagnosis of Simian Infections
VII. Prevention and Control
VIII. Simian Herpesviruses as Zoonotic Agents
IX. Epidemiologic Features of H. simiae Infection in Man
X. Pathogenesis in Man
XI. Clinical Features
XII. Clinical and Laboratory Diagnosis
XIII. Preventive Measures
References
Chapter 14 Viruses of Other Vertebrates
I. Introduction
II. Bovine Herpesvirus-1 Infections: Infectious Bovine Rhinotracheitis, Infectious Pustular Vulvovaginitis
III. Bovine Herpesvirus-2 Infection: Bovine Herpesvirus Mammillitis
IV. Equine Herpesvirus Infections: Equine Rhinopneumonitis, Equine Coital Exanthema
V. Porcine Herpesvirus Infection: Pseudorabies
VI. Canine Herpesvirus Infection
VII. Feline Herpesvirus Infection: Feline Viral Rhinotracheitis
VIII. Cottontail Herpesvirus Infection
IX. Herpesvirus Infection of Chickens: Infectious Laryngotracheitis
References
Chapter 15 Herpesviruses of Lower Vertebrates
I. Introduction
II. Reptilian Hosts
III. Teleostean Fish Hosts
IV. Specific Pathogen-Free Test Animals
References
Chapter 16 The Epstein-Barr Virus
I. History
II. Virus-Cell Relationships
III. EB Virus and Infectious Mononucleosis
IV. Relationship between EB Virus and Burkitt's Lymphoma (BL)
V. Relationship between EB Virus and other Lymphoproliferative Diseases
VI. Relationship between EB Virus and Nasopharyngeal Carcinoma
VII. Cell-Mediated Immunity
VIII. Discussion
References
Chapter 17 Marek's Disease
I. Introduction
II. Clinical Disease
III. Pathology
IV. Etiology
V. Virology
VI. Epizootiology
VII. Control
References
Chapter 18 Herpesvirus saimiri
I. Introduction
II. Studies in Vitro
III. Natural History
IV. Pathogenesis of Diseases Caused by Herpesvirus saimiri
V. Discussion
VI. Addendum
References
Chapter 19 The Lucké Renal Carcinoma of the Frog
I. Introduction
II. The Tumor
III. Properties of the Lucké Tumor-Associated Herpesvirus
References
Chapter 20 Chemotherapy—Molecular Aspects
I. 5-Iodo-2'-Deoxyuridine (IUdR, IdUrd, IdU, Idoxuridine)
II. 6-Azauracil Ribonucleoside (6-Azauridine)
III. 5-Ethyl-2'-Deoxyuridine
IV. Trifluoromethyl-2'-Deoxyuridine
V. 1-ß-D-Arabinofuranosyl Cytosine (Arabinosyl Cytosine, Cytosine Arabinoside)
VI. 9-ß-D-Arabinofuranosyl Adenine (Adenine Arabinoside)
VII. Conclusion
References
Chapter 21 Chemotherapy of Herpesviruses—Clinical Aspects
I. Introduction
II. Antiviral Chemotherapy in Experimental Herpes Infections of Laboratory Animals
III. Herpetic (HSV) Keratitis in Man
IV. Herpesvirus Infections with Prominent Skin Lesions (Simplex, Zoster, Varicella)
V. Herpesvirus Encephalitis
VI. Conclusions
References
Author Index
Subject Index